BioLargo CEO Dennis Calvert joins Natalie Stoberman from the Proactive studios to share more details behind the addition of Nicholas Valeriani and Linda Park to its subsidiary Clyra Medical Technologies' Board of Directors.
Nicholas Valeriani has decades of executive experience in the medical device industry. He spent 34 years at Johnson & Johnson (NYSE:JNJ), where he led several corporate functions and was a member of its executive committee.
Linda Park is a trusted executive and legal professional with a proven track record of supporting and advising public companies at the corporate board and executive level at billion-dollar corporations.